Cargando…
Development of a Plasmodium berghei transgenic parasite expressing the full-length Plasmodium vivax circumsporozoite VK247 protein for testing vaccine efficacy in a murine model
BACKGROUND: The approach of using transgenic rodent malaria parasites to assess the immune system’s response to antigenic targets from a human malaria parasite has been shown to be useful for preclinical evaluation of new vaccine formulations. The transgenic Plasmodium berghei parasite line [PvCSP(V...
Autores principales: | Mizutani, Masanori, Fukumoto, Shinya, Soubeiga, Adam Patrice, Soga, Akira, Iyori, Mitsuhiro, Yoshida, Shigeto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851775/ https://www.ncbi.nlm.nih.gov/pubmed/27129682 http://dx.doi.org/10.1186/s12936-016-1297-3 |
Ejemplares similares
-
Serological responses to a soluble recombinant chimeric Plasmodium vivax circumsporozoite protein in VK210 and VK247 population
por: Cheng, Yang, et al.
Publicado: (2013) -
Prevalence of Plasmodium vivax VK210 and VK247 subtype in Myanmar
por: Kim, Tong-Soo, et al.
Publicado: (2010) -
VK210 and VK247 genotypes of Plasmodium vivax in anopheline mosquitoes from Brazilian Amazon
por: Santos, Erian de Almeida, et al.
Publicado: (2019) -
Serological responses to a soluble recombinant circumsporozoite protein-VK210 of Plasmodium vivax (rPvCSP-VK210) among Iranian malaria patients
por: Nateghpour, Mehdi, et al.
Publicado: (2021) -
Improvement of an in vitro drug selection method for generating transgenic Plasmodium berghei parasites
por: Soga, Akira, et al.
Publicado: (2019)